Comparing the Ketogenic Effect of Coconut Oil and Different MCTs

NCT ID: NCT02679222

Last Updated: 2020-04-06

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-06-30

Study Completion Date

2017-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to compare the ketogenic effect of coconut oil and three MCT oils (60-40 , tricaprylin and triheptanoate) on the production of ketones in healthy adults. Each oil are evaluated individually or in combination over a 8h-period during which repeated blood sampling is performed.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study is composed of eight successive visits. Each visit consists of the consumption of one individual oil or a mixture of oils (20 g of coconut oil or 10 g of coconut oil + 10 g of MCT 60-40 or 20 g MCT 60-40 or 10 g coconut oil + 10 g tricaprylin or 20 g tricaprylin or 10 g coconut oil + 10 g triheptanoate or 20 g triheptanoate) and a 8h follow-up during which repeated blood samples are taken for laboratory analysis (plasma beta-hydroxybutyrate, acetoacetate, glucose, free fatty acids, triglycerides, total cholesterol, lactate and insulin).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Adults

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Supplementation

Protocol involved seven separate but identical metabolic study days for each participant. the test substances were evaluated in random order: vehicle (Control) or 20 mL of the test oils (Coconut oil; tricaprin; tricaprylin; MCT \[tricaprylin/tricaprin\]; coconut oil + MCT \[50:50\]; Coconut oil + tricaprylin \[50:50\]) taken twice, once at breakfast and once at mid-day.

Group Type EXPERIMENTAL

Coconut oil

Intervention Type DIETARY_SUPPLEMENT

20 g of coconut oil

Coconut oil + MCT

Intervention Type DIETARY_SUPPLEMENT

10 g of coconut oil + 10 g of MCT (60 of C8 + 40 of C10)

MCT

Intervention Type DIETARY_SUPPLEMENT

20 g of MCT (60 of C8+40 of C10)

Coconut oil + tricaprylin

Intervention Type DIETARY_SUPPLEMENT

10 g coconut oil + 10 g tricaprylin

Tricaprylin

Intervention Type DIETARY_SUPPLEMENT

20 g tricaprylin

Tricaprin

Intervention Type DIETARY_SUPPLEMENT

20 g tricaprin

Control

Intervention Type DIETARY_SUPPLEMENT

No supplement taken on this visit

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Coconut oil

20 g of coconut oil

Intervention Type DIETARY_SUPPLEMENT

Coconut oil + MCT

10 g of coconut oil + 10 g of MCT (60 of C8 + 40 of C10)

Intervention Type DIETARY_SUPPLEMENT

MCT

20 g of MCT (60 of C8+40 of C10)

Intervention Type DIETARY_SUPPLEMENT

Coconut oil + tricaprylin

10 g coconut oil + 10 g tricaprylin

Intervention Type DIETARY_SUPPLEMENT

Tricaprylin

20 g tricaprylin

Intervention Type DIETARY_SUPPLEMENT

Tricaprin

20 g tricaprin

Intervention Type DIETARY_SUPPLEMENT

Control

No supplement taken on this visit

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Coco Coco+MCT Coco+C8 C8 C10 CTL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy adult over 18 y old.

Exclusion Criteria

* Fasting plasma glucose ≥7.0 mM (diabetics or pre-diabetics);
* Smoking
* Clinically-significant gastro-intestinal disease/conditions.
* Clinically-significant liver disease/dysfunction.
* Clinically-significant cardiac disease/conditions.
* Clinically-significant abnormal coagulation.
* Taking a medication that could affect lipid and glucose metabolism
* Hypertension
* Pregnancy or breastfeeding
* Exercising more than 3 times a week
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Université de Sherbrooke

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stephen Cunnane, PhD

Role: PRINCIPAL_INVESTIGATOR

CSSS-IUGS - CIUSSS de L'Estrie - CHUS - Université de Sherbrooke

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Research Centre on Aging (CSSS-IUGS - CIUSSS de l'Estrie - CHUS)

Sherbrooke, Quebec, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2016-541

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Oil, Fats and Oleogel Study
NCT02702726 COMPLETED NA
Exogenous Ketones and Glucose Tolerance
NCT03461068 COMPLETED PHASE1